Long-Term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia

Bhidayasiri, 2011, Spectrum of tardive syndromes: clinical recognition and management, Postgrad Med J, 87, 132, 10.1136/pgmj.2010.103234 Aquino, 2014, Tardive dyskinesia syndromes: current concepts, Parkinsonism Relat Disord, 20, S113, 10.1016/S1353-8020(13)70028-2 Waln, 2013, An update on tardive dyskinesia: from phenomenology to treatment, Tremor Other Hyperkinet Mov (N Y), 3, 1 Savitt, 2018, Tardive syndromes, J Neurol Sci, 389, 35, 10.1016/j.jns.2018.02.005 Caroff, 2011, Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial, Neurol Clin, 29, 127, 10.1016/j.ncl.2010.10.002 Patterson-Lomba, 2019, Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: a retrospective data analysis, BMC Neurol, 19, 174, 10.1186/s12883-019-1385-4 Sajatovic, 2020, The effects of valbenazine on tardive dyskinesia in older and younger patients, Int J Geriatr Psychiatry, 35, 69, 10.1002/gps.5218 Hayes, 2012, Functional status and all-cause mortality in serious mental illness, PLoS One, 7, e44613, 10.1371/journal.pone.0044613 Woerner, 1998, Prospective study of tardive dyskinesia in the elderly: rates and risk factors, Am J Psychiatry, 155, 1521, 10.1176/ajp.155.11.1521 Lerner, 2015, Tardive dyskinesia (syndrome): current concept and modern approaches to its management, Psychiatry Clin Neurosci, 69, 321, 10.1111/pcn.12270 Yassa, 1985, Complications of tardive dyskinesia: a review, Psychosomatics, 26, 305, 10.1016/S0033-3182(85)72863-0 Niemann, 2019, Deutetrabenazine in the treatment of tardive dyskinesia, Neurodegener Dis Manag, 9, 59, 10.2217/nmt-2018-0042 Fernandez, 2017, Randomized controlled trial of deutetrabenazine for tardive dyskinesia: the ARM-TD study, Neurology, 88, 2003, 10.1212/WNL.0000000000003960 Anderson, 2017, Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial, Lancet Psychiatry, 4, 595, 10.1016/S2215-0366(17)30236-5 Fernandez, 2019, Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia, J Neurol Neurosurg Psychiatry, 90, 1317 Jeste, 2013, Treating older adults with schizophrenia: challenges and opportunities, Schizophr Bull, 39, 966, 10.1093/schbul/sbt043 Calati, 2013, Antidepressants in elderly: metaregression of double-blind, randomized clinical trials, J Affect Disord, 147, 1, 10.1016/j.jad.2012.11.053 Olfson, 2015, Antipsychotic treatment of adults in the United States, J Clin Psychiatry, 76, 1346, 10.4088/JCP.15m09863